Literature DB >> 9673480

Ocular and orbital complications following the treatment of retinoblastoma.

I Anteby1, N Ramu, L Gradstein, H Miskin, J Pe'er, D Benezra.   

Abstract

PURPOSE: To investigate the ocular and orbital complications observed in children treated for retinoblastoma. SUBJECTS AND METHODS: We retrospectively studied 73 children (39 boys, 34 girls) suffering from retinoblastoma. Thirty-six had bilateral tumor and 37 unilateral disease for a total of 109 eyes affected. The follow-up was 6-180 months (median 36 months). Enucleation was the most common initial treatment approach in the unilateral group, and radiotherapy (by external beam) was the most common initial therapy in the bilateral group. Cryotherapy, photocoagulation, brachytherapy and/or systemic chemotherapy were used as adjuvant treatments when necessary. Ocular complications were recorded at the follow-up examinations.
RESULTS: Cataract developed in 20% of the irradiated eyes. The mean time from irradiation until development of cataract was 28.5 months (6-64 months). Radiation retinopathy developed in 12% and was first detected 11-72 months (mean 37 months) after irradiation therapy. Mild transient keratopathy was observed in all eyes undergoing irradiation, and xerophthalmia in one eye. Complications after enucleation included: marked discharge from the socket (11.0%), extrusion of the implant (9.6%), and contraction of the socket (3.0%). No complications were observed after cryotherapy or laser photocoagulation of the tumor.
CONCLUSIONS: Ocular complications after treating children with retinoblastoma are common and may seriously affect the quality of life of children surviving the primary malignancy.

Entities:  

Mesh:

Year:  1998        PMID: 9673480     DOI: 10.1177/112067219800800210

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  6 in total

1.  The effect of cancer therapies on pediatric anophthalmic sockets.

Authors:  Yevgeniy Shildkrot; Maria Kirzhner; Barrett G Haik; Ibrahim Qaddoumi; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  Ophthalmology       Date:  2011-12       Impact factor: 12.079

2.  Risk of cataract extraction among adult retinoblastoma survivors.

Authors:  Gabriel Chodick; Ruth A Kleinerman; Marilyn Stovall; David H Abramson; Johanna M Seddon; Susan A Smith; Margaret A Tucker
Journal:  Arch Ophthalmol       Date:  2009-11

3.  Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.

Authors:  Qasiem J Nasser; Dan S Gombos; Michelle D Williams; B Ashleigh Guadagnolo; William H Morrison; Adam S Garden; Beth M Beadle; Elvia Canseco; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 May-Jun       Impact factor: 1.746

4.  Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.

Authors:  Dong Yoon Kim; Jeong A Choi; Jae-Young Koh; Young Hee Yoon
Journal:  J Exp Clin Cancer Res       Date:  2016-11-04

5.  Molecular Insights on Post-chemotherapy Retinoblastoma by Microarray Gene Expression Analysis.

Authors:  Venkatesan Nalini; Ramya Segu; Perinkulam Ravi Deepa; Vikas Khetan; Madavan Vasudevan; Subramanian Krishnakumar
Journal:  Bioinform Biol Insights       Date:  2013-09-18

6.  Radiation-Induced Ocular Surface Disorders and Retinopathy: Ocular Structures and Radiation Dose-Volume Effect.

Authors:  Ozlem Ozkaya Akagunduz; Suzan Guven Yilmaz; Emin Tavlayan; Mine Esen Baris; Filiz Afrashi; Mustafa Esassolak
Journal:  Cancer Res Treat       Date:  2021-06-24       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.